actemra solution
hoffmann-la roche limited - tocilizumab - solution - 400mg - tocilizumab 400mg - disease-modifying antirheumatic agents
actemra solution
hoffmann-la roche limited - tocilizumab - solution - 162mg - tocilizumab 162mg - disease-modifying antirheumatic agents
xeljanz comprimé
pfizer canada ulc - tofacitinib (citrate de tofacitinib) - comprimé - 5mg - tofacitinib (citrate de tofacitinib) 5mg - disease-modifying antirheumatic agents
kevzara solution
sanofi-aventis canada inc - sarilumab - solution - 150mg - sarilumab 150mg - disease-modifying antirheumatic agents
kevzara solution
sanofi-aventis canada inc - sarilumab - solution - 200mg - sarilumab 200mg - disease-modifying antirheumatic agents
xeljanz xr comprimé (à libération prolongée)
pfizer canada ulc - tofacitinib (citrate de tofacitinib) - comprimé (à libération prolongée) - 11mg - tofacitinib (citrate de tofacitinib) 11mg - disease-modifying antirheumatic agents
kevzara solution
sanofi-aventis canada inc - sarilumab - solution - 150mg - sarilumab 150mg - disease-modifying antirheumatic agents
kevzara solution
sanofi-aventis canada inc - sarilumab - solution - 200mg - sarilumab 200mg - disease-modifying antirheumatic agents
olumiant comprimé
eli lilly canada inc - baricitinib - comprimé - 2mg - baricitinib 2mg - immunosuppressive agents
xeljanz comprimé
pfizer canada ulc - tofacitinib (citrate de tofacitinib) - comprimé - 10mg - tofacitinib (citrate de tofacitinib) 10mg - disease-modifying antirheumatic agents